← Leaderboards
Christine A Petersen
Harvard University (Sch Of Public Hlth)
$6,352,199
Attributed
$8,790,308
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,790,308 · 9
By mechanism
R01$7,271,869 · 3
R21$491,052 · 1
R56$411,744 · 1
P20$330,743 · 3
K08$284,900 · 1
Top collaborators
- Maria Gomes-Solecki4 shared
- Jacob Oleson4 shared
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseInfectionPreventCanis FamiliarisCohortImmunityTransmission ProcessComplexExperimental StudyPublic HealthVaccinationResponseImmuneParasitesLeishmaniasisNorth AmericaInnovationLigandsCellsEnvironmentExposure ToMacrophageLaboratoriesImmune Response
Grant awards (23)
Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis$560,277
R01 · FY2025 · AI · contact PI
Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis$566,035
R01 · FY2024 · AI · contact PI
Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis$619,780
R01 · FY2023 · AI · contact PI
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$693,311
R01 · FY2022 · AI · contact PI
Alteration of skin immune environment by sand fly saliva across progressive Leishmaniasis$649,558
R01 · FY2022 · AI · contact PI
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$705,010
R01 · FY2021 · AI · contact PI
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$840,738
R01 · FY2020 · AI · contact PI
Epidemic modeling framework for complex, multi-species disease processes$460,961
R01 · FY2020 · TW
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$733,280
R01 · FY2019 · AI · contact PI
Epidemic modeling framework for complex, multi-species disease processes$471,276
R01 · FY2019 · TW
Epidemic modeling framework for complex, multi-species disease processes$481,120
R01 · FY2018 · TW
B cell/T Follicular Helper cell interactions in progression of Leishmaniasis$411,744
R56 · FY2018 · AI · contact PI
Epidemic modeling framework for complex, multi-species disease processes$490,523
R01 · FY2017 · TW
Role of pathogen-derived capping carbohydrates in altering immunity$100,051
R21 · FY2010 · AI · contact PI
Role of pathogen-derived capping carbohydrates in altering immunity$213,685
R21 · FY2009 · AI · contact PI
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC$95,445
P20 · FY2009 · RR · contact PI
Role of pathogen-derived capping carbohydrates in altering immunity$177,316
R21 · FY2008 · AI · contact PI
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC$93,484
P20 · FY2008 · RR · contact PI
BIOMEDICAL RESEARCH AND TRAINING AT COLLEGE OF THE ATLANTIC$141,814
P20 · FY2007 · RR · contact PI
Trypanosoma cruzi-elicited cardiac hypertrophy$79,656
K08 · FY2004 · AI
Trypanosoma cruzi-elicited cardiac hypertrophy$17,490
K08 · FY2004 · AI
Trypanosoma cruzi-elicited cardiac hypertrophy$94,945
K08 · FY2003 · AI
Trypanosoma cruzi-elicited cardiac hypertrophy$92,809
K08 · FY2002 · AI